Market updates, summit announcements and investment intelligence from the UK medical cannabis sector. Verified sources only. Updated regularly.
The UK medical cannabis market is approaching a £1 billion annual valuation and is expected to support 100,000 patients in 2026, according to industry analysis reported by LBC following a visit to Glass Pharms — one of the UK's largest Home Office-licensed cannabis cultivation facilities, located in Wiltshire.
Read at LBC →Mamedica — one of the UK's leading medical cannabis clinics with over 15,000 patients treated — was ranked number 8 in the Sunday Times 100 list of the fastest-growing private companies in the UK in 2026, validating the commercial momentum behind the UK's medical cannabis clinic sector and the growing interest of institutional capital in the space.
Read at Sunday Times →Germany's medical cannabis market — now the largest in Europe — reached an estimated €670 million in annual value in 2025, with over 100,000 patients receiving cannabis under Germany's statutory health insurance reimbursement system. The European medical cannabis market is projected to reach €2–4 billion by 2028 — providing a clear benchmark for UK market trajectory.
Read at Cannabis Europa →Subscribe to receive UK medical cannabis investment news and summit updates directly.
Subscribe for Updates →